Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure.

Hauptman PJ, Schnitzler MA, Swindle J, Burroughs TE.

JAMA. 2006 Oct 18;296(15):1877-84.

PMID:
17047218
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.

Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K.

JAMA. 2005 Apr 20;293(15):1900-5.

PMID:
15840865
[PubMed - indexed for MEDLINE]
3.

Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.

Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.

Pharmacotherapy. 2006 Aug;26(8):1078-85.

PMID:
16863484
[PubMed - indexed for MEDLINE]
Free Article
4.

Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.

Yancy CW.

Drug Saf. 2007;30(9):765-81. Review.

PMID:
17722969
[PubMed - indexed for MEDLINE]
5.

Impact of nesiritide on renal function and mortality in patients suffering from heart failure.

Dontas ID, Xanthos T, Dontas I, Lelovas P, Papadimitriou L.

Cardiovasc Drugs Ther. 2009 Jun;23(3):221-33. doi: 10.1007/s10557-009-6167-6. Review.

PMID:
19252976
[PubMed - indexed for MEDLINE]
6.

The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.

Dandamudi S, Chen HH.

Expert Rev Cardiovasc Ther. 2012 May;10(5):557-63. doi: 10.1586/erc.12.31.

PMID:
22651831
[PubMed - indexed for MEDLINE]
7.

Effect of nesiritide in patients with acute decompensated heart failure.

O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM.

N Engl J Med. 2011 Jul 7;365(1):32-43. doi: 10.1056/NEJMoa1100171. Erratum in: N Engl J Med. 2011 Aug 25;365(8):773. Wilson, W H [corrected to Tang, W H W].

PMID:
21732835
[PubMed - indexed for MEDLINE]
Free Article
8.

Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.

Schwarz ER, Najam S, Akel R, Sulimanjee N, Bionat S, Rosanio S.

J Cardiovasc Pharmacol Ther. 2007 Sep;12(3):232-6.

PMID:
17875951
[PubMed - indexed for MEDLINE]
9.

Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.

Hiestand B, Abraham WT.

Curr Cardiol Rep. 2007 May;9(3):182-6. Review.

PMID:
17470330
[PubMed - indexed for MEDLINE]
10.

Patterns of change in nesiritide use in patients with heart failure: how hospitals react to new information.

Partovian C, Li SX, Xu X, Lin H, Strait KM, Hwa J, Krumholz HM.

JACC Heart Fail. 2013 Aug;1(4):318-24. doi: 10.1016/j.jchf.2013.04.005. Epub 2013 Aug 5.

PMID:
24621935
[PubMed - indexed for MEDLINE]
11.

Nesiritide: a review of its use in acute decompensated heart failure.

Keating GM, Goa KL.

Drugs. 2003;63(1):47-70. Review.

PMID:
12487622
[PubMed - indexed for MEDLINE]
12.

Observation unit treatment of heart failure with nesiritide: results from the proaction trial.

Peacock WF 4th, Holland R, Gyarmathy R, Dunbar L, Klapholz M, Horton DP, de Lissovoy G, Emerman CL.

J Emerg Med. 2005 Oct;29(3):243-52.

PMID:
16183441
[PubMed - indexed for MEDLINE]
13.

Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).

van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O'Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA.

Circulation. 2014 Sep 16;130(12):958-65. doi: 10.1161/CIRCULATIONAHA.113.003046. Epub 2014 Jul 29.

PMID:
25074507
[PubMed - indexed for MEDLINE]
14.

Short and long-term mortality with nesiritide.

Arora RR, Venkatesh PK, Molnar J.

Am Heart J. 2006 Dec;152(6):1084-90.

PMID:
17161057
[PubMed - indexed for MEDLINE]
15.

Nesiritide for acute decompensated heart failure: does the benefit justify the risk?

Sackner-Bernstein J, Aaronson KD.

Curr Cardiol Rep. 2007 May;9(3):187-93. Review.

PMID:
17470331
[PubMed - indexed for MEDLINE]
16.

Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.

Noviasky JA.

Pharmacotherapy. 2007 May;27(5):626-32. Review.

PMID:
17461696
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of nesiritide in patients with acute decompensated heart failure.

DeWald TA, Hernandez AF.

Expert Rev Cardiovasc Ther. 2010 Feb;8(2):159-69. doi: 10.1586/erc.09.173. Review.

PMID:
20136602
[PubMed - indexed for MEDLINE]
18.

Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.

Miller AH, Nazeer S, Pepe P, Estes B, Gorman A, Yancy CW.

Ann Emerg Med. 2008 May;51(5):571-8. doi: 10.1016/j.annemergmed.2007.12.003. Epub 2008 Mar 4.

PMID:
18304693
[PubMed - indexed for MEDLINE]
19.

Nesiritide: harmful or harmless?

Dorsch MP, Rodgers JE.

Pharmacotherapy. 2006 Oct;26(10):1465-78. Review.

PMID:
16999657
[PubMed - indexed for MEDLINE]
20.

Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.

Gerhard T, Zineh I, Winterstein AG, Hartzema AG.

Pharmacotherapy. 2006 Jan;26(1):34-43.

PMID:
16509026
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk